Literature DB >> 15379672

The role of STATs in inflammation and inflammatory diseases.

E Pfitzner1, S Kliem, D Baus, C M Litterst.   

Abstract

The immune response is regulated by the concerted action of pro- and anti-inflammatory cytokines. The deregulation of this process causes immunological disorders like allergic and autoimmune diseases. The Janus Kinase (JAK)--Signal transducer and activator of transcription (STAT) pathway is one major signaling pathway converting the cytokine signal into gene expression programs regulating the proliferation and differentiation of the immune cells. Several members of the STAT protein family in particular STAT1, STAT2, STAT3, STAT4 and STAT6 act as transcription factors in modulating pro- and anti-inflammatory responses. Here we review the evidence for the involvement of the different STAT proteins in inflammation, autoimmune and allergic diseases. We discuss novel approaches to interfere with the function of these signaling transcription factors for therapeutic purpose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379672     DOI: 10.2174/1381612043383638

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  48 in total

1.  JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Susan A Kadlubar; Kristina L Bondurant; Roger K Wolff
Journal:  Mol Carcinog       Date:  2011-11-28       Impact factor: 4.784

Review 2.  The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Int Immunopharmacol       Date:  2010-12-22       Impact factor: 4.932

Review 3.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

Review 4.  The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.

Authors:  Sylvane Desrivières; Christian Kunz; Itamar Barash; Vida Vafaizadeh; Corina Borghouts; Bernd Groner
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

5.  Daphnetin reduces endotoxin lethality in mice and decreases LPS-induced inflammation in Raw264.7 cells via suppressing JAK/STATs activation and ROS production.

Authors:  Lei Shen; Ting Zhou; Jing Wang; Xiumei Sang; Lei Lan; Lan Luo; Zhimin Yin
Journal:  Inflamm Res       Date:  2017-04-13       Impact factor: 4.575

6.  Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22.

Authors:  Tomoki Kikuchi; Taeko K Naruse; Makoto Onizuka; Suyun Li; Tetsuaki Kimura; Akira Oka; Yasuo Morishima; Jerzy K Kulski; Shingo Ichimiya; Noriyuki Sato; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2007-01-03       Impact factor: 2.846

7.  Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1.

Authors:  Sudip K Bandyopadhyay; Carol A de la Motte; Sean P Kessler; Vincent C Hascall; David R Hill; Scott A Strong
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

8.  Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice.

Authors:  Melissa E Gove; Davina H Rhodes; Maria Pini; Jantine W van Baal; Joseph A Sennello; Raja Fayad; Robert J Cabay; Martin G Myers; Giamila Fantuzzi
Journal:  J Leukoc Biol       Date:  2008-12-03       Impact factor: 4.962

9.  1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1.

Authors:  Pavlo L Kovalenko; Zhentao Zhang; Min Cui; Steve K Clinton; James C Fleet
Journal:  BMC Genomics       Date:  2010-01-13       Impact factor: 3.969

Review 10.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.